drugset / Trial / NCT00555009

Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury

NCT00555009

Phase 4 Terminated 10 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

To establish the effects of genotropin replacement on cognitive function in patients with severe growth hormone deficiency after traumatic brain injury.

Timeline

Start
2008-03
Primary completion
2009-01
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 0.2 mg Subcutaneous
Subject Somatropin Protein / enzyme biologic 0.3 mg Subcutaneous